Loading company…
Rigen Biotech develops molecular diagnostics products, medical consumables and testing platforms.
Rigen Biotech develops and sells medical consumables and PCR and NGS testing platforms for applications including thyroid disease, oncology and pathogen testing. Founded in Shanghai in 2017, it raised approximately CNY 100.00 million in Series B funding in May 2025, led by Efung Capital with participation from Shanghai Fengxian Investment (Group).
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in